These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1074 related articles for article (PubMed ID: 17707010)

  • 41. Oxybutynin efficacy in the treatment of primary enuresis.
    Lovering JS; Tallett SE; McKendry JB
    Pediatrics; 1988 Jul; 82(1):104-6. PubMed ID: 3288951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diuretic treatment of nocturnal enuresis.
    Nevéus T; Johansson E; Nydahl-Persson K; Peterson H; Hansson S
    Scand J Urol Nephrol; 2005; 39(6):474-8. PubMed ID: 16303723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary monosymptomatic nocturnal enuresis in children and adolescents.
    Lottmann HB; Alova I
    Int J Clin Pract Suppl; 2007 Sep; (155):8-16. PubMed ID: 17727574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH; Kamperis K; Hagstroem S; Bower WF; Rittig S
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The system of management nocturnal enuresis based on functional classification].
    Kroll P; Zachwieja J
    Przegl Lek; 2006; 63 Suppl 3():229-32. PubMed ID: 16898539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
    Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion.
    Dehoorne JL; Raes AM; van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2006 Aug; 176(2):749-53. PubMed ID: 16813935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary and secondary nocturnal enuresis: similarities in presentation.
    Robson WL; Leung AK; Van Howe R
    Pediatrics; 2005 Apr; 115(4):956-9. PubMed ID: 15805370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nocturnal enuresis.
    Thiedke CC
    Am Fam Physician; 2003 Apr; 67(7):1499-506. PubMed ID: 12722850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults.
    Burgu B; Gökce MI; Gücük A; Soygür T
    Urology; 2009 Oct; 74(4):915-9. PubMed ID: 19643460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis.
    Leebeek-Groenewegen A; Blom J; Sukhai R; Van Der Heijden B
    J Urol; 2001 Dec; 166(6):2456-8. PubMed ID: 11696811
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL; Leung AK; Norgaard JP
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Enuresis and common bladder disorders in children].
    Cochat P
    Pediatrie; 1989; 44(7):523-30. PubMed ID: 2812969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.
    Toren P; Ratner S; Laor N; Lerer-Amisar D; Weizman A
    Neuropsychobiology; 2005; 51(4):239-42. PubMed ID: 15897675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Desmopressin is a safe drug for the treatment of enuresis.
    Del Gado R; Del Gaizo D; Cennamo M; Auriemma R; Del Gado G; Vernì M
    Scand J Urol Nephrol; 2005; 39(4):308-12. PubMed ID: 16118106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresis.
    Vogt M; Lehnert T; Till H; Rolle U
    BJU Int; 2010 May; 105(10):1456-9. PubMed ID: 19764973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No relationship between family history of enuresis and response to desmopressin.
    Schaumburg HL; Rittig S; Djurhuus JC
    J Urol; 2001 Dec; 166(6):2435-7. PubMed ID: 11696806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nocturnal enuresis: a suggestive endophenotype marker for a subgroup of inattentive attention-deficit/hyperactivity disorder.
    Elia J; Takeda T; Deberardinis R; Burke J; Accardo J; Ambrosini PJ; Blum NJ; Brown LW; Lantieri F; Berrettini W; Devoto M; Hakonarson H
    J Pediatr; 2009 Aug; 155(2):239-44.e5. PubMed ID: 19446845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.